Human interferon omega-1

DB05472InvestigationalProtein Based Therapies

Human interferon omega 1 (IFN-omega 1 = IFN-alpha II1) is a recently discovered protein structurally related to IFN-alpha and -beta. It occurs naturally in the human body and is currently... It occurs naturally in the human body and is currently being manufactured by Intarcia through genetic engineering.

Mechanism: Independent studies demonstrate that interferon omega binds to the alpha/beta receptor, but not the interferon gamma receptor.
Curator reviewed
Primary indication: Investigated for use/treatment in hepatitis (viral, C).Curator reviewed
Also known as: Human interferon omega 1 · IFN-ω · IFNW1 · Interferon omega-1 · Interferon-omega

Resolves to

Targets

P17181IFNAR1P48551IFNAR2

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

500Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Human interferon omega-1, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account